Details of the Drug Inactive Ingredient (DIG)
General Information of DIG (ID: E0J4OX) | |||||
---|---|---|---|---|---|
DIG Name |
Hydroxypropyl cellulose
|
||||
DIG Function |
Binding agent; Coating agent; Emulsifying agent; Film/Membrane-forming agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
|
||||
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
Metronidazole
|
API Info |
Amebiasis [ICD-11: 1A36]
|
[1] | |||
Raltegravir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[2] | |||
ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
Enasidenib
|
API Info |
Acute myeloid leukemia [ICD-11: 2A60]
|
[3] | |||
Osimertinib
|
API Info |
Lung cancer [ICD-11: 2C25]
|
[4] | |||
Alectinib
|
API Info |
Lung cancer [ICD-11: 2C25]
|
[5] | |||
Cabozantinib
|
API Info |
Thyroid cancer [ICD-11: 2D10]
|
[6] | |||
ICD Disease Classification 03 | Blood/blood-forming organ disease | Click to Show/Hide | ||||
Ruxolitinib
|
API Info |
Thrombocytosis [ICD-11: 3B63]
|
[7] | |||
ICD Disease Classification 04 | Immune system disease | Click to Show/Hide | ||||
Cetirizine
|
API Info |
Allergy [ICD-11: 4A80]
|
[8] | |||
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Atorvastatin
|
API Info |
Hyperlipidaemia [ICD-11: 5C8Z]
|
[9] | |||
Fluvastatin
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[10] | |||
Alogliptin
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[11] | |||
Lorcaserin
|
API Info |
Obesity [ICD-11: 5B81]
|
[12] | |||
Pitavastatin
|
API Info |
Hyperlipidaemia [ICD-11: 5C8Z]
|
[13] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Bupropion
|
API Info |
Nicotine dependence [ICD-11: 6C4A]
|
[14] | |||
Sertraline
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[15] | |||
Cyclobenzaprine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[16] | |||
Imipramine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[17] | |||
Fluphenazine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[18] | |||
Trifluoperazine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[19] | |||
Vortioxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[20] | |||
Thioridazine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[21] | |||
Naltrexone
|
API Info |
Alcohol dependence [ICD-11: 6C40]
|
[22] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Galantamine
|
API Info |
Alzheimer disease [ICD-11: 8A20]
|
[23] | |||
Donepezil
|
API Info |
Alzheimer disease [ICD-11: 8A20]
|
[24] | |||
Tiagabine
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[25] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Warfarin
|
API Info |
Atrial fibrillation [ICD-11: BC81]
|
[26] | |||
Clonidine
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[27] | |||
Losartan
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[28] | |||
Clopidogrel
|
API Info |
Deep vein thrombosis [ICD-11: BD71]
|
[29] | |||
Prasugrel
|
API Info |
Myocardial infarction [ICD-11: BA41]
|
[30] | |||
Quinapril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[31] | |||
Dabigatran etexilate
|
API Info |
Venous thromboembolism [ICD-11: BD72]
|
[32] | |||
Moexipril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[33] | |||
ICD Disease Classification 12 | Respiratory system disease | Click to Show/Hide | ||||
Budesonide
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[34] | |||
Cefpodoxime
|
API Info |
Bronchitis [ICD-11: CA20]
|
[35] | |||
ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
Pantoprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[36] | |||
Famotidine
|
API Info |
Peptic ulcer [ICD-11: DA61]
|
[37] | |||
ICD Disease Classification 14 | Skin disease | Click to Show/Hide | ||||
Pseudoephedrine
|
API Info |
Erythema multiforme [ICD-11: EB12]
|
[38] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Raloxifene
|
API Info |
Osteoporosis [ICD-11: FB83]
|
[39] | |||
Tofacitinib
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[40] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
Oxidoreductase (ORase) | ||||||
DBT Name: Mephenytoin 4-hydroxylase (CYP2C19) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | EC50 = 89.5 uM (tested by experiment) | [41] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2CJ_HUMAN | |||||
DBT Name: Debrisoquine 4-hydroxylase (CYP2D6) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | EC50 = 148.3 uM (tested by experiment) | [41] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2D6_HUMAN | |||||
Lyase/isomerase/ligase (L/I/G) | ||||||
DBT Name: Cholesterol 25-hydroxylase (CYP1A2) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | EC50 = 139 uM (tested by experiment) | [41] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP1A2_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.